Cyproheptadine Hydrochloride Tablet
Product Images NDC 70710-1110

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70710-1110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyproheptadine HCl Tablet (B36a8686 4b30 4b42 A673 44cc58b775c3 01)

Chemical structure of cyproheptadine hydrochloride, showing the molecular arrangement of the active ingredient with a hydrochloride component represented separately.*

FDA Label Image

Cyproheptadine Hydrochloride Tablets Usp, 4 mg (B36a8686 4b30 4b42 A673 44cc58b775c3 02)

Label for Cyproheptadine Hydrochloride Tablets USP 4 mg by Zydus Pharmaceuticals USA Inc. The label indicates a 100 tablet package, with dosage strength of 4 mg per tablet. Storage instructions, child-resistant packaging note, manufacturer (Zydus Lifesciences Ltd., India), and distributor details are also shown. The label includes a barcode and NDC 70710-1110-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.